December 10, 2024

Columbus Post

Complete News World

Vaccine against lung cancer: This is how an mRNA vaccine works – News

Vaccine against lung cancer: This is how an mRNA vaccine works – News

For the first time, a patient has received an mRNA vaccine against lung cancer. And this is within a framework Medical examination In Great Britain. Biontech’s vaccine is now being tested in Great Britain, Germany, Hungary, Poland, Spain, Turkey and the United States. About 130 patients from early stages of the disease to advanced stages or recurrent cancer are expected to participate in this first phase of the trial. SRF Science Editor Nina-Lou Frey knows the background.

Nina-Lou Frey

SRF Scientific Editor


Open the People box
Persson-Box suction cups

Nina-Lou Frey has been working at SRF since 2021 in the Science Editorial Department. He has previously worked in various media organizations in print, online, radio and television and has completed his studies in Communication Science and Journalism.

Why is the mRNA vaccine coming now?

The pandemic has given a huge boost to mRNA technology. Scientists have been using this technology for a long time, but only because of the pandemic more money is flowing into this area. I mean: there’s a lot going on right now. Research is currently underway on mRNA vaccines for cancer types such as breast, prostate, colon and pancreatic cancer.

The doctor injects the vaccine into the patient's hand.
Legend:

A lung cancer vaccine is currently being tested. (thumbnail)

KEYSTONE/BIONTECH SE/HANDOUT

Why Lung Cancer?

Lung cancer has the highest mortality rate of all cancers worldwide: about 1.8 million people die from it every year. Lung cancer is the second most commonly diagnosed cancer in the country.

Even after lung cancer patients have surgery and radiation, the cancer can come back. This is where Biotech’s new mRNA vaccine makes progress. But: A clinical trial of a new mRNA vaccine called “BNT116” is still in its early stages. Results will not be available until 2027. Further studies with more participants are then needed. It takes years for patients to continue receiving this treatment.

How do mRNA vaccines work?

First we know the vaccinations to keep you from getting sick. On the other hand, mRNA vaccines are for people who already have cancer. They are therapeutic vaccines. It trains the immune system to recognize and attack cancer cells.

Cancer is a collective term; Each type has its own mutations. Not only are cancer types different from each other, but each patient’s cancer is different. If two people have the same form of lung cancer, the vaccine may work for one but not the other.

Can a vaccine replace current treatments?


Open the box
Box zuklappen

It doesn’t necessarily have to be a substitute, says Nina-Lou Frey, SRF science editor. “But it’s another treatment option. The hope of the research is that the vaccine can be added when no other treatment has helped. For example, with pancreatic cancer—a type of cancer with a survival rate of about twelve percent.” According to Frey, it’s possible that these treatments have fewer side effects because they specifically target cancer cells than conventional methods.

How does the vaccine help the immune system of the infected?

In all of us, the immune system is constantly on the lookout for foreign substances, pathogens or cancer cells in the body. And cancer cells are basically being created all the time. The immune system always recognizes and destroys them. But sometimes cancer cells are able to hide themselves from the immune system. Or the immune system becomes exhausted. A vaccine is an attempt to reactivate the immune system so that it can fight cancer cells again.

Part of British matchmaking


Open the box
Box zuklappen

The newly launched study is part of British “matchmaking” between patients and vaccine manufacturers. The UK provides companies with data on the characteristics of all cancer patients’ tumors if they agree. Researchers use this database to find suitable participants for their study. Its aim is to advance the development of new vaccines.

The specialty of the new mRNA vaccines is that a vaccine is prepared for each patient. But even if the vaccine is tailored to the characteristics of individual tumor cells, an mRNA vaccine may not work as intended.

See also  Garbage Run: A scrap rally passes through Switzerland